Sarah Cannon Research Institute
Sarah Cannon Research Institute
Nashville, TN, United States
Disclosure(s): Contract Research: Abbvie (Terminated); Accutar Biotechnology (Terminated); Arcus Biosciences (Terminated); AstraZeneca (Terminated); AVEO Oncology (Terminated); CRISPR Therapeutics (Terminated); Exelixis (Terminated); Harbour BioMed (Terminated); IDEAYA Biosciences (Terminated); Janssen (Terminated); JANUX Therapeutics (Terminated); Jubilant Therapeutics (Terminated); Kineta (Terminated); Kinnate BioPharma (Terminated); Loxo/Lilly (Terminated); Mink Therapeutics (Terminated); Nuvation Bio Inc (Terminated); PROfound Bio (Terminated); roche genetech (Terminated); Teon Therapeutics (Terminated); Xencor (Terminated); Zenshine (Terminated)
Non-CE Consulting: Amgen (Terminated); Arvinas (Terminated); Bayer (Terminated); Merck (Terminated); Pfizer (Terminated); Sanofi/Aventis (Terminated); SeaGen (Terminated)